Yahoo Web Search

Search results

  1. May 1, 2024 · A pioneer in AI biotechnology. Completing her PhD at Stanford University in 1993, Daphne’s research interests are primarily in representation, inference, learning and decision-making and their applications to computer vision and computational biology. Her work in this field led her to be elected a member of the National Academy of Engineering ...

  2. May 15, 2024 · AI pioneer and insitro CEO Daphne Koller is betting it will—at the very least—supercharge the hunt for new drugs. She breaks down her strategy in this Institute Dialogue with Paul McCracken, CPP Investments’ Managing Director Growth Equity and Nadeem Janmohamad, Managing Director Active Equities North America.

  3. People also ask

  4. May 16, 2024 · AI pioneer Daphne Koller is betting it will—at the very least—supercharge the hunt for new drugs. In this issue, Koller explains the strategy behind her AI-first company, Jon Webster explores how generative AI is reshaping work and Priti Singh asks where companies are headed with equity diversity and inclusion.

  5. 5 days ago · How Insitro’s big hires help it push AI drug discovery. Daphne Koller, founder and CEO of Insitro, is seeking to combine large clinical and cellular data sets with machine learning technology...

  6. Daphne Koller Net Worth – Coursera Co-founder and Computer scientist Daphne Koller is an Israeli-American computer scientist. She is a co-founder of Coursera.

  7. May 16, 2024 · CPP Investments | Investissements RPC. 872 subscribers. Subscribed. 1. 30 views 1 day ago. Will artificial intelligence find the cure for what ails us? AI pioneer and insitro CEO Daphne Koller...

  8. May 20, 2024 · AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality. By Casey Ross and Matthew Herper. Reprints. From left: Daphne Koller, CEO of Insitro, Vijay ...

  1. People also search for